LEXICON PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2022-03-10
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2020-12-31 was $0.00.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2020-09-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2020-06-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2021 was $0.00.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2020 was $0.00.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2019 was -$25.99M.
- LEXICON PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2018 was -$22.94M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-10 | |||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-10 | $0.00 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $0.00 derived: sum of 2 quarters · filed 2020-10-30 | $0.00 10-Q · filed 2020-10-30 | -$61.00K derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $0.00 10-Q · filed 2020-07-29 | -$61.00K derived: sum of 3 quarters · filed 2022-03-10 | -$25.45M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2020-04-27 | -$61.00K derived: sum of 2 quarters · filed 2022-03-10 | -$25.45M derived: sum of 3 quarters · filed 2022-03-10 | -$26.00M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2019-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$25.45M derived: sum of 2 quarters · filed 2022-03-10 | -$26.00M derived: sum of 3 quarters · filed 2022-03-10 | -$25.99M 10-K · filed 2022-03-10 | ||||
| 2019-09-30 | -$25.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$25.94M derived: sum of 2 quarters · filed 2020-10-30 | -$25.93M 10-Q · filed 2020-10-30 | -$23.34M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$535.00K 10-Q · filed 2020-07-29 | $2.05M derived: sum of 3 quarters · filed 2021-03-12 | $1.73M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $9.00K 10-Q · filed 2020-04-27 | $2.60M derived: sum of 2 quarters · filed 2021-03-12 | $2.28M derived: sum of 3 quarters · filed 2021-03-12 | -$3.96M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.27M derived: sum of 2 quarters · filed 2021-03-12 | -$3.97M derived: sum of 3 quarters · filed 2021-03-12 | -$22.94M 10-K · filed 2021-03-12 | -$24.00M 10-K · filed 2019-03-15 | |||
| 2018-09-30 | -$321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$6.56M derived: sum of 2 quarters · filed 2019-11-07 | -$25.53M 10-Q · filed 2019-11-07 | -$25.21M 10-Q · filed 2018-11-01 | -$39.64M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | -$6.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$25.21M 10-Q · filed 2019-08-01 | -$25.00M 10-Q · filed 2018-07-30 | -$39.32M derived: sum of 3 quarters · filed 2020-03-12 | -$55.54M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | -$18.97M 10-Q · filed 2019-05-01 | -$18.80M 10-Q · filed 2018-05-03 | -$33.08M derived: sum of 2 quarters · filed 2020-03-12 | -$49.30M derived: sum of 3 quarters · filed 2020-03-12 | -$55.72M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | -$14.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$30.34M derived: sum of 2 quarters · filed 2020-03-12 | -$36.75M derived: sum of 3 quarters · filed 2020-03-12 | -$51.13M 10-K · filed 2020-03-12 | $49.78M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | -$16.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$22.64M derived: sum of 2 quarters · filed 2018-11-01 | -$37.02M 10-Q · filed 2018-11-01 | -$54.94M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | -$6.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$20.80M 10-Q · filed 2018-07-30 | $20.80M 10-Q · filed 2017-08-01 | -$38.72M derived: sum of 3 quarters · filed 2019-03-15 | -$121.99M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2017-03-31 | -$14.38M 10-Q · filed 2018-05-03 | $14.38M 10-Q · filed 2017-05-04 | -$32.30M derived: sum of 2 quarters · filed 2019-03-15 | -$115.58M derived: sum of 3 quarters · filed 2019-03-15 | -$95.83M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2016-12-31 | -$17.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$101.20M derived: sum of 2 quarters · filed 2019-03-15 | -$81.45M derived: sum of 3 quarters · filed 2019-03-15 | -$69.26M 10-K · filed 2019-03-15 | $73.34M 10-K · filed 2017-03-06 | |||
| 2016-09-30 | -$83.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$63.53M derived: sum of 2 quarters · filed 2017-11-08 | -$51.34M 10-Q · filed 2017-11-08 | $51.34M 10-Q · filed 2016-11-07 | -$223.54M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $19.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $31.93M 10-Q · filed 2017-08-01 | -$140.26M derived: sum of 3 quarters · filed 2018-03-01 | -$139.79M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $12.19M 10-Q · filed 2017-05-04 | -$160.01M derived: sum of 2 quarters · filed 2018-03-01 | -$159.54M derived: sum of 3 quarters · filed 2018-03-01 | -$159.44M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | -$172.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$171.72M derived: sum of 2 quarters · filed 2018-03-01 | -$171.63M derived: sum of 3 quarters · filed 2018-03-01 | -$171.35M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $568.00K derived: sum of 2 quarters · filed 2016-11-07 | $846.00K 10-Q · filed 2016-11-07 | $13.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $371.00K 10-Q · filed 2016-08-04 | -$462.00K derived: sum of 3 quarters · filed 2017-03-06 | -$370.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | $278.00K 10-Q · filed 2016-05-05 | -$555.00K derived: sum of 2 quarters · filed 2017-03-06 | -$463.00K derived: sum of 3 quarters · filed 2017-03-06 | -$437.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | -$833.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$741.00K derived: sum of 2 quarters · filed 2017-03-06 | -$715.00K derived: sum of 3 quarters · filed 2017-03-06 | -$697.00K 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $118.00K derived: sum of 2 quarters · filed 2015-11-09 | $136.00K 10-Q · filed 2015-11-09 | $626.00K derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $44.00K 10-Q · filed 2015-08-07 | $534.00K derived: sum of 3 quarters · filed 2016-03-11 | $472.00K derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $18.00K 10-Q · filed 2015-05-05 | $508.00K derived: sum of 2 quarters · filed 2016-03-11 | $446.00K derived: sum of 3 quarters · filed 2016-03-11 | $451.00K derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $428.00K derived: sum of 2 quarters · filed 2016-03-11 | $433.00K derived: sum of 3 quarters · filed 2016-03-11 | $438.00K 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | -$62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$57.00K derived: sum of 2 quarters · filed 2014-11-06 | -$52.00K 10-Q · filed 2014-11-06 | $241.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $10.00K 10-Q · filed 2014-08-07 | $303.00K derived: sum of 3 quarters · filed 2015-03-12 | $303.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $5.00K 10-Q · filed 2014-05-08 | $298.00K derived: sum of 2 quarters · filed 2015-03-12 | $298.00K derived: sum of 3 quarters · filed 2015-03-12 | $298.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $293.00K derived: sum of 2 quarters · filed 2015-03-12 | $293.00K derived: sum of 3 quarters · filed 2015-03-12 | $293.00K 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $45.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $0.00 10-Q · filed 2013-08-01 | $45.00K derived: sum of 3 quarters · filed 2014-03-07 | $19.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | $45.00K derived: sum of 2 quarters · filed 2014-03-07 | $19.00K derived: sum of 3 quarters · filed 2014-03-07 | $66.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2011-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $19.00K derived: sum of 2 quarters · filed 2014-03-07 | $66.00K derived: sum of 3 quarters · filed 2014-03-07 | $95.00K 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $21.00K derived: sum of 2 quarters · filed 2012-11-07 | $50.00K 10-Q · filed 2012-11-07 | $683.00K derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $76.00K 10-Q · filed 2012-08-02 | $709.00K derived: sum of 3 quarters · filed 2013-03-11 | $376.00K derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-03-31 | $29.00K 10-Q · filed 2012-05-03 | $662.00K derived: sum of 2 quarters · filed 2013-03-11 | $329.00K derived: sum of 3 quarters · filed 2013-03-11 | |||||
| 2010-12-31 | $633.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $300.00K derived: sum of 2 quarters · filed 2013-03-11 | $728.00K 10-K · filed 2013-03-11 | |||||
| 2010-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $95.00K 10-Q · filed 2011-11-01 | ||||||
| 2010-06-30 | $428.00K 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $4.73M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |